Anteris Technologies
Anteris Technologies is dedicated to revolutionizing cardiac care by developing innovative, science-driven solutions that restore healthy heart function. Their focus is on disrupting heart valve disease through cutting-edge, biomimetic transcatheter heart valves designed to mimic native heart physiology.
Industries
Nr. of Employees
medium (51-250)
Anteris Technologies
Products
Biomimetic transcatheter heart valve system
A transcatheter aortic valve system using a single-piece, native-shaped biomimetic valve geometry combined with treated biological tissue designed to resist calcification and a balloon-expandable delivery platform for transcatheter implantation.
Biomimetic transcatheter heart valve system
A transcatheter aortic valve system using a single-piece, native-shaped biomimetic valve geometry combined with treated biological tissue designed to resist calcification and a balloon-expandable delivery platform for transcatheter implantation.
Services
Design and execution of first-in-human and early feasibility clinical studies for implantable transcatheter heart valves, including imaging follow-up and one-year outcome assessment.
Support for animal studies and preclinical evaluation of novel structural heart devices and repair systems.
Preparation of investor presentations, periodic SEC/ASX filings, press releases and coordination with analysts and transfer agents.
Design and execution of first-in-human and early feasibility clinical studies for implantable transcatheter heart valves, including imaging follow-up and one-year outcome assessment.
Support for animal studies and preclinical evaluation of novel structural heart devices and repair systems.
Preparation of investor presentations, periodic SEC/ASX filings, press releases and coordination with analysts and transfer agents.
Expertise Areas
- Transcatheter aortic valve replacement (TAVR) device development
- Biomaterials and anti-calcification tissue engineering
- Clinical trial design and execution (FIH, EFS)
- Cardiac imaging and 4D flow CMR analysis
Key Technologies
- Biomimetic valve design
- Anti-calcification tissue treatment
- Balloon-expandable catheter delivery
- 4D flow cardiac MRI (4D Flow CMR)
News & Updates
Annual General Meeting 2024
The recording of the Annual General Meeting including strategic updates and future plans.
DurAVR® THV Clinical Data Update at Sydney Valves
Data demonstrating favorable hemodynamic profile and zero prosthesis-patient mismatch in small annuli patients.
MRI Data Update on First-in-Human Study at London Valves
Cardiac MRI analyses comparing flow dynamics and LV function between DurAVR® THV recipients and healthy controls.
TCT 2024 Physician Panel Interview
Discussion on MRI flow & LV mass data, impact of valve design on flow, and disease regression.
New York Valves 2024 Symposium
Experts discuss the biomimetic design of DurAVR® THV and its impact on hemodynamics and blood flow.
Update on DurAVR® THV Valve-in-Valve Experience
Restoration of hemodynamic performance in complex valve-in-valve cases.
Annual General Meeting 2024
The recording of the Annual General Meeting including strategic updates and future plans.
DurAVR® THV Clinical Data Update at Sydney Valves
Data demonstrating favorable hemodynamic profile and zero prosthesis-patient mismatch in small annuli patients.
MRI Data Update on First-in-Human Study at London Valves
Cardiac MRI analyses comparing flow dynamics and LV function between DurAVR® THV recipients and healthy controls.
TCT 2024 Physician Panel Interview
Discussion on MRI flow & LV mass data, impact of valve design on flow, and disease regression.
New York Valves 2024 Symposium
Experts discuss the biomimetic design of DurAVR® THV and its impact on hemodynamics and blood flow.
Update on DurAVR® THV Valve-in-Valve Experience
Restoration of hemodynamic performance in complex valve-in-valve cases.